3

3-D Matrix Ltd
TSE:7777

Watchlist Manager
3-D Matrix Ltd
TSE:7777
Watchlist
Price: 428 JPY -4.89% Market Closed
Market Cap: ¥51.4B

Operating Margin

-3.1%
Current
Improving
by 55.1%
vs 3-y average of -58.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.1%
=
Operating Income
¥-263.5m
/
Revenue
¥8.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.1%
=
Operating Income
¥-263.5m
/
Revenue
¥8.5B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
3-D Matrix Ltd
TSE:7777
51.5B JPY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
395.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.8B USD
Loading...

Market Distribution

Lower than 93% of companies in Japan
Percentile
7th
Based on 6 730 companies
7th percentile
-3.1%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

3-D Matrix Ltd
Glance View

Market Cap
51.4B JPY
Industry
Biotechnology

3-D Matrix Ltd. engages in the research, development, manufacture, and sale of medical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 69 full-time employees. The company went IPO on 2011-10-24. The firm has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.

Intrinsic Value
342.81 JPY
Overvaluation 20%
Intrinsic Value
Price
3
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-3.1%
=
Operating Income
¥-263.5m
/
Revenue
¥8.5B
What is 3-D Matrix Ltd's current Operating Margin?

The current Operating Margin for 3-D Matrix Ltd is -3.1%, which is above its 3-year median of -58.2%.

How has Operating Margin changed over time?

Over the last 3 years, 3-D Matrix Ltd’s Operating Margin has increased from -162% to -3.1%. During this period, it reached a low of -162% on Oct 1, 2022 and a high of -3.1% on Dec 1, 2025.

Back to Top